6-Amino-2-oxo-1,2-dihydropyrimidine-5-carbaldehyde

Catalog No.: 
ACYZPO210
CAS No.: 
4425-59-6
Molecular Formula: 
C5H5N3O2
Molecular Weight: 
139.11
6-Amino-2-oxo-1,2-dihydropyrimidine-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg97%$112.00InquiryInquiry
10mg97%$178.00InquiryInquiry
25mg97%$406.00InquiryInquiry
50mg97%$732.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Amino-2-oxo-1,2-dihydropyrimidine-5-carbaldehyde
IUPAC Name6-amino-2-oxo-1,2-dihydropyrimidine-5-carbaldehyde
Molecular FormulaC5H5N3O2
Molecular Weight139.11
SMILESO=CC(C=N1)=C(N)NC1=O
InChI KeyFHSISDGOVSHJRW-UHFFFAOYSA-N
Synonym5-Pyrimidinecarboxaldehyde, 4-amino-1,2-dihydro-2-oxo- (7CI,8CI,9CI);6-amino-2-oxo-1,2-dihydropyrimidine-5-carbaldehyde;4-amino-2-hydroxypyrimidine-5-carbaldehyde;4-Amino-1,2-dihydro-2-oxo-5-pyrimidinecarboxaldehyde;5-Pyrimidinecarboxaldehyde, 6-amino-1,2-dihydro-2-oxo-
CAS No.4425-59-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACYZPO210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZABT964 route compound structure diagram
    ACZABT9641123-95-1In Stock
  2. Then
  3. ACYZPO210 route product structure diagram
    ACYZPO2104425-59-6
Inquiry

2. ACYZPO210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYZPO210 route product structure diagram
    ACYZPO2104425-59-6
Inquiry

3. ACYZPO210 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYZPO210 route product structure diagram
    ACYZPO2104425-59-6
Inquiry

Comments (0)